Results 181 to 190 of about 50,215 (225)

Prognostic scoring based on ER, PgR and HER2-low from the CYCLHER study: strengths and unaddressed challenges for global clinical application. [PDF]

Breast
Tan Y, Cheng B, Feng Z, He K, Xie X.
europepmc   +1 more source

Enhanced antibacterial, antibiofilm, and antioxidant potential of ciprofloxacin-loaded SDS-capped silver nanoparticles against resistant bacterial strains. [PDF]

Discov Nano
Fareed M, Farid N, Dar MS, Ali K, Bashir A.   +4 more
europepmc   +1 more source

Biosynthesis of ecofriendly antibacterial nanoparticles with healing effects in a murine diabetic skin infection model. [PDF]

Sci Rep
Mustafa EA, Nada HG, Eraqi WA, Shamma RN, Elhifnawi HN, Abdeltawab NF.   +5 more
europepmc   +1 more source

Unmet support and information needs of relatives of patients with advanced or metastatic breast cancer: results of the BRE-BY-MED study. [PDF]

Support Care Cancer
Brandstetter LS, Grau A, Löffler J, Müller-Reiter M, Salmen J, Reese JP, Heuschmann P, Wöckel A.   +7 more
europepmc   +1 more source

Log odds of positive lymph nodes predicts survival in metaplastic breast cancer based on SEER analysis. [PDF]

Discov Oncol
Chen Q, Shao Y, Liu C, He Y, Liu H.
europepmc   +1 more source

Synergistic effects of 13-year warming and nitrogen fertilization accelerating soil carbon destabilization in North China Plain farmland. [PDF]

Front Microbiol
Zhang C, Dong W, Wang J, Li W, Zhang R, Li X, Liu X, Yang Y, Zhang Y, Hu C.   +9 more
europepmc   +1 more source

From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2- breast cancer. [PDF]

Breast
Stachyra P, Hernando Meliá C, López-Guerrero JA, Gavilá Gregori J, Guerrero-Zotano ÁL.   +4 more
europepmc   +1 more source